Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Apr 15, 2025; 17(4): 104253
Published online Apr 15, 2025. doi: 10.4251/wjgo.v17.i4.104253
Published online Apr 15, 2025. doi: 10.4251/wjgo.v17.i4.104253
Figure 5 The relapse-free survival and overall survival curves for the initial circulating tumor cell counts of the patients with cholangio carcinoma, and the relapse-free survival curve for RASSF1A methylation.
A and B: The progression free survival and overall survival curves for the initial circulating tumor cell counts before therapy in the patients with cholangiocarcinoma; C: The progression free survival curves for the RASSF1A methylation in the patients with cholangiocarcinoma. CTC: Circulating tumor cell.
- Citation: Yu J, Liu QC, Lu SY, Wang S, Zhang H. Detecting plasma SHOX2, HOXA9, SEPTIN9, and RASSF1A methylation and circulating cancer cells for cholangiocarcinoma clinical diagnosis and monitoring. World J Gastrointest Oncol 2025; 17(4): 104253
- URL: https://www.wjgnet.com/1948-5204/full/v17/i4/104253.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i4.104253